MX9100967A - USE OF THE RADIOACTIVE METAL ION COMPLEX WITH ALLCIS-1,3,5-TRIAMINO-2,4,5-CYCLLOHEXANOTRIOL AND ITS DERIVATIVES FOR X-RAY DIAGNOSTIC PURPOSES AND IN TUMOR THERAPY AS WELL AS THE PREPARATION OF MEDIA FOR PURPOSES OF - Google Patents

USE OF THE RADIOACTIVE METAL ION COMPLEX WITH ALLCIS-1,3,5-TRIAMINO-2,4,5-CYCLLOHEXANOTRIOL AND ITS DERIVATIVES FOR X-RAY DIAGNOSTIC PURPOSES AND IN TUMOR THERAPY AS WELL AS THE PREPARATION OF MEDIA FOR PURPOSES OF

Info

Publication number
MX9100967A
MX9100967A MX9100967A MX9100967A MX9100967A MX 9100967 A MX9100967 A MX 9100967A MX 9100967 A MX9100967 A MX 9100967A MX 9100967 A MX9100967 A MX 9100967A MX 9100967 A MX9100967 A MX 9100967A
Authority
MX
Mexico
Prior art keywords
purposes
cycllohexanotriol
allcis
triamino
derivatives
Prior art date
Application number
MX9100967A
Other languages
Spanish (es)
Inventor
Isidor Erni
Walter Schneider
Hans Kaspar Heggetschweiler
Peter Geisser
Original Assignee
Hausmann Ag Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hausmann Ag Labor filed Critical Hausmann Ag Labor
Publication of MX9100967A publication Critical patent/MX9100967A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9100967A 1990-09-05 1991-09-05 USE OF THE RADIOACTIVE METAL ION COMPLEX WITH ALLCIS-1,3,5-TRIAMINO-2,4,5-CYCLLOHEXANOTRIOL AND ITS DERIVATIVES FOR X-RAY DIAGNOSTIC PURPOSES AND IN TUMOR THERAPY AS WELL AS THE PREPARATION OF MEDIA FOR PURPOSES OF MX9100967A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4028139A DE4028139A1 (en) 1990-09-05 1990-09-05 USE OF THE COMPLEX RADIOACTIVE METALLIONS WITH ALL-CIS-1,3,5-TRIAMINO-2,4,6-CYCLOHEXANTRIOL AND ITS DERIVATIVES FOR X-RAY DIAGNOSTIC PURPOSES AND IN TUMOR THERAPY AND THE PRODUCTION OF MEDICINE AND FUTURE AND FUTURE AND FURNITURE AND FUTURE

Publications (1)

Publication Number Publication Date
MX9100967A true MX9100967A (en) 1992-05-04

Family

ID=6413642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100967A MX9100967A (en) 1990-09-05 1991-09-05 USE OF THE RADIOACTIVE METAL ION COMPLEX WITH ALLCIS-1,3,5-TRIAMINO-2,4,5-CYCLLOHEXANOTRIOL AND ITS DERIVATIVES FOR X-RAY DIAGNOSTIC PURPOSES AND IN TUMOR THERAPY AS WELL AS THE PREPARATION OF MEDIA FOR PURPOSES OF

Country Status (10)

Country Link
EP (1) EP0504339A1 (en)
JP (1) JPH05502456A (en)
KR (1) KR920702235A (en)
AU (1) AU658148B2 (en)
CA (1) CA2073050A1 (en)
DE (1) DE4028139A1 (en)
MX (1) MX9100967A (en)
PT (1) PT98869A (en)
TW (1) TW197951B (en)
WO (1) WO1992004056A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US20150132229A1 (en) 2012-05-18 2015-05-14 Bayer Pharma Aktiengesellschaft Bis azainositol heavy metal complexes for x-ray imaging
EP2796152A1 (en) 2013-04-25 2014-10-29 Bayer Pharma Aktiengesellschaft Unsymmetrical Bis Azainositol Hafnium Complexes for X-Ray Imaging
EP2873670A1 (en) 2013-11-14 2015-05-20 Bayer Pharma Aktiengesellschaft Bis azainositol zirconium complexes for X-ray imaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3503614A1 (en) * 1985-02-02 1986-08-07 Laboratorien Hausmann AG, St. Gallen ALL-CIS-1,3,5-TRIAMINO-2,4,6-CYCLOHEXANTRIOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
CH679742A5 (en) * 1990-01-09 1992-04-15 Byk Gulden Lomberg Chem Fab

Also Published As

Publication number Publication date
DE4028139A1 (en) 1992-03-12
TW197951B (en) 1993-01-11
AU658148B2 (en) 1995-04-06
PT98869A (en) 1992-07-31
CA2073050A1 (en) 1992-03-06
AU8436791A (en) 1992-03-30
EP0504339A1 (en) 1992-09-23
KR920702235A (en) 1992-09-03
WO1992004056A1 (en) 1992-03-19
JPH05502456A (en) 1993-04-28

Similar Documents

Publication Publication Date Title
GB2004448B (en) X-ray collimator and computed axial tomography apparatus employing said collimator
HK15285A (en) Diagnostic means,process for its preparation and its use in determining leucocytes in body fluids
IT8247635A0 (en) COMPLEXES OF CYCLODEXTRINS AND CARDIAC GLYCOSIDES FOR THERAPEUTIC USE AND PREPARATION PROCEDURE
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
GB2063668B (en) Beta-cyclodextrin for use in the treatment of acne
AR230060A1 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 3-AMINOSIANONIMIA, SUBSTITUTED AMINO ACETONITRILE FOR ITS EXCLUSIVE USE IN SUCH PROCEDURE AND PROCEDURE FOR ITS PREPARATION
NO163435C (en) PATIENT CHAIR FOR X-ray examinations.
GB2058510B (en) Positron annihilation imaging device having movable collimator
PH16228A (en) Triazolo pyridazine derivatives,pharmaceutical composition containing the same and their use
GB2108657B (en) Device for the measurement of the radiation dose versus depth in soft tissues
HK30581A (en) Process for the preparation of 6,6'-oxy bis(4-halo-2h-pyran-3(6h)-ones)and their use in preparing gamma-pyrones
MX9100967A (en) USE OF THE RADIOACTIVE METAL ION COMPLEX WITH ALLCIS-1,3,5-TRIAMINO-2,4,5-CYCLLOHEXANOTRIOL AND ITS DERIVATIVES FOR X-RAY DIAGNOSTIC PURPOSES AND IN TUMOR THERAPY AS WELL AS THE PREPARATION OF MEDIA FOR PURPOSES OF
IT8349080A0 (en) PAJAMAS EQUIPPED WITH CLOSABLE OPENINGS FOR BODY INSPECTION, PARTICULARLY FOR HOSPITAL PATIENTS
GB2076660B (en) Application unit for epicutaneous testing or treatment
WO1997005904A3 (en) Use of metal clusters as a contrast or radiotherapy agent
IT1173473B (en) PROCEDURE FOR THE PREPARATION OF 1,8-DIHYDROXY-10-ACYL-9-ANTRONES, IN PARTICULAR FOR USE IN THE TREATMENT OF PSORIASIS
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
Hayes et al. Compartmentalized phantoms for the standard man, adolescent and child
IT7869661A0 (en) APPARATUS FOR THE IRRADIATION OF ULTRAVIOLET RAYS, PARTICULARLY FOR MEDICAL OR COSMETIC USE
GB2198150B (en) Membrane for use in x-ray mask and method for preparing the same
IT1093956B (en) CONDUCT FOR LIQUIDS DIVIDED INTO TWO PARTS, EQUIPPED WITH MEANS FOR THE COUPLING BETWEEN THE TWO PARTS OF THE CONDUCT, ESPECIALLY FOR MEDICAL USE
IT8048370A0 (en) AGENT FOR THE DIAGNOSIS OF TUMORS AND PROCEDURE FOR ITS TREATMENT
ZA786908B (en) In vitro testing method for the diagnosis of malignant tumours
IT7929007V0 (en) DEVICE FOR LOCKING THE POSITION OF MECHANICAL ORGANS IN PARTICULAR OF THE BACKREST OF ARMCHAIRS AND SEATS
GB2015873B (en) Medical treatment chair